Attenuation of Vesicular Stomatitis Virus Encephalitis through MicroRNA Targeting
- 1 February 2010
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 84 (3), 1550-1562
- https://doi.org/10.1128/jvi.01788-09
Abstract
Vesicular stomatitis virus (VSV) has long been regarded as a promising recombinant vaccine platform and oncolytic agent but has not yet been tested in humans because it causes encephalomyelitis in rodents and primates. Recent studies have shown that specific tropisms of several viruses could be eliminated by engineering microRNA target sequences into their genomes, thereby inhibiting spread in tissues expressing cognate microRNAs. We therefore sought to determine whether microRNA targets could be engineered into VSV to ameliorate its neuropathogenicity. Using a panel of recombinant VSVs incorporating microRNA target sequences corresponding to neuron-specific or control microRNAs (in forward and reverse orientations), we tested viral replication kinetics in cell lines treated with microRNA mimics, neurotoxicity after direct intracerebral inoculation in mice, and antitumor efficacy. Compared to picornaviruses and adenoviruses, the engineered VSVs were relatively resistant to microRNA-mediated inhibition, but neurotoxicity could nevertheless be ameliorated significantly using this approach, without compromise to antitumor efficacy. Neurotoxicity was most profoundly reduced in a virus carrying four tandem copies of a neuronal mir125 target sequence inserted in the 3′-untranslated region of the viral polymerase (L) gene.Keywords
This publication has 52 references indexed in Scilit:
- MicroRNAs and the Regulation of Vector TropismMolecular Therapy, 2009
- Biological basis for restriction of microRNA targets to the 3′ untranslated region in mammalian mRNAsNature Structural & Molecular Biology, 2009
- Use of Biological Therapy to Enhance Both Virotherapy and Adoptive T-Cell Therapy for CancerMolecular Therapy, 2008
- Generation of a Conditionally Replicating Adenovirus Based on Targeted Destruction of E1A mRNA by a Cell Type-Specific MicroRNAJournal of Virology, 2008
- Harnessing Endogenous miRNAs to Control Virus Tissue Tropism as a Strategy for Developing Attenuated Virus VaccinesCell Host & Microbe, 2008
- Radioiodide imaging and radiovirotherapy of multiple myeloma using VSV(Δ51)-NIS, an attenuated vesicular stomatitis virus encoding the sodium iodide symporter geneBlood, 2007
- Neurovirulence properties of recombinant vesicular stomatitis virus vectors in non-human primatesVirology, 2007
- Myogenic factors that regulate expression of muscle-specific microRNAsProceedings of the National Academy of Sciences of the United States of America, 2006
- MicroRNA Gene Expression Deregulation in Human Breast CancerCancer Research, 2005
- Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA TargetsCell, 2005